MANCIA GIUSEPPE

Quarti Trevano, F., Bernal, S., Facchetti, R., Cuspidi, C., Mancia, G., Grassi, G. (2024). Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study. JOURNAL OF HYPERTENSION [10.1097/HJH.0000000000003709]. Dettaglio

Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M., et al. (2024). Rationale of treatment recommendations in the 2023 ESH hypertension guidelines. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 121(March 2024), 4-8 [10.1016/j.ejim.2023.12.015]. Dettaglio

Mancia, G., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Kjeldsen, S., et al. (2024). Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines. HYPERTENSION, 81(5), 1021-1030 [10.1161/HYPERTENSIONAHA.124.22821]. Dettaglio

Kreutz, R., Azizi, M., Grassi, G., Januszewicz, A., Kahan, T., Lurbe, E., et al. (2024). Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?. BLOOD PRESSURE, 33(1) [10.1080/08037051.2024.2317263]. Dettaglio

Rist, A., Sevre, K., Wachtell, K., Devereux, R., Aurigemma, G., Smiseth, O., et al. (2024). The current best drug treatment for hypertensive heart failure with preserved ejection fraction. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 120(February 2024), 3-10 [10.1016/j.ejim.2023.10.008]. Dettaglio